|
GPR137C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30460000002941E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.22549997611566E-09 |
| Normal-vs-Stage2 |
2.331700E-02 |
| Normal-vs-Stage3 |
1.043220E-01 |
| Normal-vs-Stage4 |
1.020990E-01 |
| Stage1-vs-Stage2 |
2.861000E-01 |
| Stage1-vs-Stage3 |
2.284300E-03 |
| Stage1-vs-Stage4 |
6.809600E-01 |
| Stage2-vs-Stage3 |
2.783600E-01 |
| Stage2-vs-Stage4 |
8.421400E-01 |
| Stage3-vs-Stage4 |
3.673600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32629999996625E-06 |
| Normal-vs-AfricanAmerican |
1.144280E-02 |
| Normal-vs-Asian |
1.202610E-01 |
| Caucasian-vs-AfricanAmerican |
4.120200E-01 |
| Caucasian-vs-Asian |
6.574000E-01 |
| AfricanAmerican-vs-Asian |
3.088000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.16860000000252E-05 |
| Normal-vs-Female |
4.48419999999894E-05 |
| Male-vs-Female |
4.887200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.077600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.04740000001136E-06 |
| Normal-vs-Age(61-80Yrs) |
1.217710E-03 |
| Normal-vs-Age(81-100Yrs) |
7.845600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.604000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.171600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.429610E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.376200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.955750E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.132300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.418100E-03 |
| Normal-vs-Grade 2 |
4.73579997439799E-09 |
| Normal-vs-Grade 3 |
1.552070E-02 |
| Normal-vs-Grade 4 |
3.096200E-01 |
| Grade 1-vs-Grade 2 |
2.908200E-01 |
| Grade 1-vs-Grade 3 |
2.172500E-02 |
| Grade 1-vs-Grade 4 |
8.322000E-02 |
| Grade 2-vs-Grade 3 |
1.202570E-03 |
| Grade 2-vs-Grade 4 |
1.878650E-01 |
| Grade 3-vs-Grade 4 |
9.516800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.0485999996378E-07 |
| Normal-vs-ccB subtype |
7.826800E-04 |
| ccA subtype-vs-ccB subtype |
1.716770E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.246600E-04 |
| Normal-vs-N1 |
8.290000E-01 |
| N0-vs-N1 |
3.014400E-02 |
|
|
